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Background: For over 400 years, due to the reassortment of their segmented genomes, influenza viruses evolve
extremely quickly and cause devastating epidemics. This reassortment arises because two flu viruses can infect the
same cell and therefore the new virions’ genomes will be composed of segment reassortments of the two parental
strains. A treatment developed against parents could then be ineffective if the virions’ genomes are different
enough from their parent’s genomes. It is therefore essential to simulate such reassortment phenomena to assess
the risk of apparition of new flu strain.
Findings: So we decided to upgrade the forward simulator VIRAPOPS, containing already the necessary options to
handle non-segmented viral populations. This new version can mimic single or successive reassortments, in birds,
humans and/or swines. Other options such as the ability to treat populations of positive or negative sense viral
RNAs, were also added. Finally, we propose output options giving statistics of the results.
Conclusion: In this paper we present a new version of VIRAPOPS which now manages the viral segment
reassortments and the negative sense single strain RNA viruses, these two issues being the cause of serious public
health problems.
Keywords: Virology, Simulator, Population genetics, Segmented genomesIntroduction
Each year worldwide, seasonal influenza causes between
three and five million cases of severe illness and 250 000
to 500 000 deaths (OMS, 2014). Its variability explains
this virulence: the low transcription fidelity and high re-
combination rate of these RNA viruses impose frequent
genomic changes. Moreover, influenza viruses (Figure 1)
possess a segmented genome (8 segments for type A and
B and 7 segments for C) which further increases this
variability. Indeed, the antigenic shift [1,2], phenomenon
where two or more different influenza viruses (called
parental viruses) may infect the same cell, can be re-
sponsible of devastating pandemics resulting from the
creation of reassorted parental segment virions. To ex-
emplify this fact, extremely virulent new strains such as
H5N1 and H7N9 (Figure 1D and [3]) have appeared as
the result of different reassortment processes.* Correspondence: anne.vanet@univ-paris-diderot.fr
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article, unless otherwise stated.Thus it becomes essential to be able to model these
processes. On one hand, a large number of DNA popu-
lation simulators [4] are not dedicated to RNA viruses
that have specific mutational capacities such as com-
pensatory mutations and synthetic lethal couples [5].
One the other hand, the small number of simulators
specifically dedicated to virus, usually manages only
the viral outbreaks [6]. These softwares do not simu-
late sequence population but rather evolution and
number of infected individuals and other simulators
handle the host-pathogen relationship [6]. Finally, the
‘reassortment and recombination’ simulator of Moedomo
et al. [7] does not take into account the population
genetic specific criteria. Yet the ‘reassortment and re-
combination’ feasibility depends directly on the viral fit-
ness and therefore on selection pressure, population
shift and drift. Ultimately the influenza simulators do
not generate nucleic or proteic sequences and the gen-
etic population simulators are not endowed with neces-
sary options for RNA viruses.Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Figure 1 Antigenic shift explains H7N9 emergence. A. Scheme
of flu virus. (gray color will be kept as meaningful for domestic
duck). 1. 8 RNA segments of the viral genome. 2. Haemagglutinin
(HA) coding segment. 3. Neuraminidase (NA) coding segment. 4. HA
protein 5. NA protein. B. Wild bird flu virus. C. Domestic poultry flu
virus. D. Sometimes, H7N9 virus made by avian RNA segment
reassortment, can infect human. Note: the combination of the 16 H
types and 9 N types can generate 144 different subtypes [9].
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The viral RNA mutability allows rapid selection of
drug resistances: some active viral proteins may have
up to 30% of their positions mutated. The conventional
population simulators are not able to model selection
pressures on groups of mutations genetically linked.
To stage these different scenarios we have developed
VIRAPOPS a forward simulator dedicated to RNA vi-
ruses, easy to use and answering questions related to
these highly specific populations. Despite that VIRA-
POPS simulates viral genetic variability through a
number of functionalities, it lacks a significant func-
tionality to simulate flu populations: it was unable to
handle the reassortment of segmented genomes, essen-
tial phenomenon in public health (see Introduction),
and negative strand RNA viruses (such as Ebola and
measles among others). Therefore, we decided to en-
rich VIRAPOPS [8], which possesses good founda-
tions to integrate these new options. Additionally, new
output options generate statistics on the obtained
sequence sets.
Mathematical models
The negative strand model is derived as follows. Let
E be the set of allowed symbols in the sequences and Φ
a bijection mapping E onto E, Φ−1 exists and is such that∀ x ∈ E,Φ(Φ− 1(x)) = x and Φ− 1(Φ(x)) = x. Furthermore,
Φ is required to be a derangement, i.e. the subset of
E such that Φ(x) = x must be void.
Here we have E = {A,C,G,T}. There is 9 possible de-
rangements: 3 circular permutations with 1 cycle of
order 4 plus their 3 inverse permutations (also circular
with 1 cycle of order 4), and 3 symmetric permutations
(i.e. Φ− 1 =Φ) containing 2 cycles of order 2. Our nega-
tive strand model is defined with such a symmetric per-
mutation: Φ(A) = T,Φ(T) =A,Φ(C) =G,Φ(G) =C.
The reassortment model has two parts. The first part
of the model is an uniform sampling without replace-
ment. Let N be the total number of sequences and n be
the number of sequences to be reassorted. There are
N !
n! N−nð Þ! subsets of n sequences among N. Thus the first
part of the model is defined by a random selection of
these subsets of n sequences, all the subsets being
equiprobable.
The second part of the model is a random shuffling.
Let K be the number of fragments. For each fragment
k ∈ {1, 2,....,K}, there are n subsequences. A random per-
mutation Pk of order n is generated with a user defined
probability depending on k, 1 ≤ k ≤ K, following the uni-
form law in the space of the n! permutations. Then each
Pk is applied to the n subsequences.
Here we have set n = 2 with planned extensions to
higher n values, and usually K = 7 or K = 8.
This option can simulate the influenza virus reassort-
ments, but also all other segmented virus reassortments,
whatever the number of segments. Thus VIRAPOPS2
may simulate rotavirus populations responsible for acute
gastroenteritis whose genetic variability is also due to
antigenic shift of its 11 segments [9].
Free binaries and documentations are available through
a software repository at http://petitjeanmichel.free.fr/ito
web.petitjean.freeware.html.
Statistics
The sequences of the population individuals derived
from the simulation was the only output of the previous
version of VIRAPOPS. In order to analyze this sequence
set, users had to rely on other software. New VIRA-
POPS2 output options allow the determination of the
number of mutation per position (DNA and protein),
the most frequent mutations per position (DNA and
protein) and finally the consensus sequences (DNA and
protein).
Negative and positive sense viral RNA
A negative single strand RNA (also called minus RNA)
codes numerous viruses, as measles, rabies, mumps and
Ebola. The previous version of VIRAPOPS only allowed
the simulation of positive RNA viruses. In this version
we added a new option where the user has to choose the
sense of the studied RNA.
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Flu from bird to man
Public health agencies want to slow emergence of new in-
fluenza strains coming from avian virus rearrangements
[10,11], e.g. the H7N9 virus which seems to come from
rearrangement of domestic ducks, wild birds and do-
mestic poultry viruses [12]. VIRAPOPS2 can predict the
occurrence of such rearranged viruses (Figure 1) and we
propose to simulate this scenario using a flu viral se-
quence from domestic duck to infect a seronegative bird.
The functional selection pressures (option 10 and 11) and
recombination (option 9) will be reproduced as explain in
Petitjean and Vanet [8] documentation. The simulator can
be launched on 80 generations (option 3) with 50 budded
virions per cycle (option 4). Then at the 40th generation,
the gene flow option (#14) allows us to simulate the infec-
tion of the bird with wild bird and domestic poultry vi-
ruses. Genetic shift option (#9) permits to model the
reassortment process with a different probability for each
segment and will be active until the end of the simulation.
If a virus issued from these 3 avian viral reassortments ap-
pears, it will be part of VIRAPOPS2 output.
Treatment and antigenic shift
An effective treatment applies a selection pressure on a
particular virus. When viruses evolve quickly, the impact
of treatment on viral populations is unknown. Therefore
yearly a new vaccine against seasonal influenza has to be
developed. To solve such problem, the simulation of the
influenza virus rearrangement (equivalent to previous
setting) will has to be compared with a new simulation
in which the treatment selection pressures (option 12)
will be included (e.g. H275Y is a neuraminidase resist-
ance mutation allowing the influenza viruses to escape
oseltamivir treatment) [13]. The comparison of the two
resulting sequence sets can determine the treatment im-
pact on rearranged viruses.
Conclusion
It is essential to describe in the same simulator all the
criteria that influence the population evolution as re-
combination, mutational variability, selection pressures,
population drifts and shifts. These options will allow the
description of the viral diversity in a given environment
and the ability to identify the virus that has the best fit-
ness and therefore the most represented in the popula-
tion. It is through these fitness determinations that the
simulator will highlight viruses that have the best chance
of survival and the possibility to invade the whole popu-
lation. These viruses have to be detected because they
will cause the next epidemic.
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